查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1965333

影像導引放射線治療市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、流程、應用、地區和競爭格局分類，2021-2031年

Image-Guided Radiation Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Procedure, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球影像導航放射治療市場預計將從 2025 年的 20.2 億美元成長到 2031 年的 27.8 億美元，複合年成長率為 5.45%。

這種先進的治療方法將磁振造影(MRI) 和電腦斷層掃描 (CT) 等常用影像通訊協定直接整合到放射治療過程中，最大限度地提高腫瘤靶向精度，同時保護周圍健康組織。市場成長的主要驅動力是全球癌症患者數量的增加，以及人們對安全性更高、療效更佳的非侵入性治療方法的偏好轉變。核能2024 年的數據證實了這一緊迫性，數據顯示，全球約 50% 至 70% 的癌症患者將需要接受放射治療，這推動了對能夠最佳化這些關鍵治療的高精度技術的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 20.2億美元
市場規模：2031年 27.8億美元
複合年成長率：2026-2031年 5.45%
成長最快的細分市場 磁振造影導引放射治療
最大的市場 北美洲

然而，由於實施和營運這些先進系統需要巨額資本投入，該市場面臨許多障礙。除了購置設備的高昂成本外，建造專用基礎設施和持續維護的財務負擔也是主要的進入門檻。這些財務限制嚴重限制了科技的普及率，尤其對中低收入地區的醫療機構影響尤其顯著，因為這些地區的醫療機構往往缺乏資金籌措來購買高成本的醫療技術。

市場促進因素

全球癌症發生率的不斷上升是影像導航放射治療市場成長的主要驅動力，因此迫切需要可擴充性的解決方案來應對日益成長的患者數量。隨著疾病負擔的加重，醫療機構不得不部署高通量系統，以確保有效控制局部疾病並最大限度地減少副作用。問題的嚴重性凸顯了這項迫切需求。世界衛生組織（WHO）下屬的國際癌症研究機構（IARC）在2024年2月發布的一份關於全球癌症負擔的新聞稿中指出，2022年全球新增癌症病例估計達2000萬例。因此，病例數量的不斷增加直接加速了放射治療設備的採購，醫院正在擴大腫瘤科以滿足不斷成長的患者群體的基本醫療需求。

同時，科技的快速發展，特別是人工智慧（AI）的融合，正在透過變革治療方式推動市場發展。現代影像導引放射治療（IGRT）平台採用自適應演算法，能夠即時校正放射束，顯著提高標靶區精度。產業向這些自適應系統的轉型已從強勁的商業業績中得到印證。例如，Accuray在2024年8月發布的「2024會計年度第四季及全年業績」中報告了3.421億美元的訂單總額，顯示市場對精密儀器的需求旺盛。西門子醫療等行業領導者也進一步支撐了該領域的財務規模。西門子醫療旗下的瓦里安部門在2024年實現了41.4億美元的總收入，主要得益於先進放射治療解決方案的持續應用。

市場挑戰

影像導航放射治療（IGRT）系統的引進和安裝需要大量資本投入，這嚴重阻礙了其在全球市場的擴張。這些先進的治療平台不僅需要購買昂貴的硬體，還需要在專用設施基礎設施（例如輻射屏蔽掩體）以及嚴格的持續維護通訊協定投入巨資。沉重的經濟負擔提高了進入門檻，限制了醫療機構（尤其是資源匱乏地區的醫療機構）取得必要設備的能力。這有效地限制了潛在基本客群，並減緩了整體普及速度。

這種經濟壁壘加劇了醫療服務取得的不平等，並直接阻礙了發展中地區（這些地區臨床需求最為迫切）的市場滲透。根據全球放射治療聯盟2024年的報告，全球約有58個國家無法提供放射治療服務，這主要是由於當地醫療系統無法負擔相關技術的初始資本和營運成本。眾多國家基礎設施的匱乏使得製造商無法進入新興市場，從而限制了全球放射治療產業的成長。

市場趨勢

生物導引放射治療平台的出現代表著市場的一次變革性演進，它將治療重點從解剖成像轉向利用腫瘤生物學進行即時標靶治療。與僅依賴結構差異的傳統系統不同，這些先進平台能夠透過偵測腫瘤直接髮射的正子斷層掃描（PET）訊號，在單次治療中精準治療多個轉移病灶。這項創新技術滿足了晚期惡性腫瘤治療的關鍵需求，而傳統的聚焦療法往往難以有效治療這些腫瘤。監管方面的進展標誌著這項技術的快速普及。正如RefleXion Medical在2025年1月發布的新聞稿「RefleXion啟動關鍵臨床試驗」中所述，更新後的報銷代碼預計將使SCINTIX療法的適用人群擴大到約40萬名患者，這表明生物驅動的工作流程已全面融入臨床實踐。

同時，基於雲端的治療計畫和數據分析的整合，正透過集中式數位生態系統最佳化複雜的腫瘤工作流程。醫療機構正在加速從孤立的現場工作站向互聯的軟體平台轉型，這些平台支援遠端計畫審查、跨中心資料交換，並提升營運效率。這種數位資源的整合使他們能夠在不相應擴充實體基礎設施的情況下，有效應對不斷成長的患者數量。這一趨勢的商業性成功已體現在近期的財務指標中。在2025年5月發布的2024/25會計年度財報中，Elekta宣布其軟體部門實現了兩位數的成長。這是其調整後息稅前利潤率達到16.3%的關鍵因素，也清楚顯示醫療服務模式正向軟體轉型。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球影像導引放射線治療市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 產品特定資訊（4D放射治療、直線加速器、MRI導引放射治療、門控CT影像）
    • 依治療方法（IMRT、立體定位放射治療、粒子束治療）
    • 依應用領域（子宮頸癌、攝護腺癌、乳癌）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美影像導引放射線治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲影像導引放射線治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區影像導引放射線治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲影像導引放射線治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲影像導引放射線治療市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球影像導引放射放射線治療市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Siemens Healthineers AG
  • ViewRay, Inc.
  • Varian Medical Systems, Inc.
  • Toshiba Corporation
  • GE HealthCare Technologies, Inc.
  • Accuray Inc.
  • Becton, Dickinson, and Company
  • Vision RT Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23746

The Global Image-Guided Radiation Therapy Market is projected to expand from USD 2.02 Billion in 2025 to USD 2.78 Billion by 2031, registering a compound annual growth rate of 5.45%. This advanced treatment modality integrates frequent imaging protocols, such as magnetic resonance imaging or computed tomography, directly into the radiation delivery process to maximize tumor targeting precision while preserving surrounding healthy tissue. The market's upward trajectory is primarily fueled by the escalating global prevalence of cancer and a shifting preference toward non-invasive therapeutic options that ensure higher safety standards and treatment effectiveness. Data from the International Atomic Energy Agency in 2024 underscores this urgency, revealing that approximately 50 to 70 percent of cancer patients worldwide require radiotherapy, thereby driving the demand for high-precision technologies capable of optimizing these critical interventions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.02 Billion
Market Size 2031USD 2.78 Billion
CAGR 2026-20315.45%
Fastest Growing SegmentMRI-guided Radiotherapy
Largest MarketNorth America

However, the market confronts substantial hurdles stemming from the immense capital expenditures necessary to procure and deploy these advanced systems. The prohibitive costs related to purchasing equipment, combined with the financial demands of specialized infrastructure construction and continuous maintenance, establish significant barriers to entry. These financial constraints severely limit adoption rates, particularly affecting healthcare institutions within low- and middle-income regions where funding for high-cost medical technologies is often restricted.

Market Driver

The escalating global incidence of cancer serves as the principal engine for growth within the Image-Guided Radiation Therapy market, creating an urgent imperative for scalable solutions capable of managing increasing patient volumes. As the burden of disease intensifies, healthcare providers are compelled to implement high-throughput systems that ensure effective localized disease control while minimizing adverse effects. This critical demand is highlighted by the scale of the issue; the World Health Organization's International Agency for Research on Cancer reported in a February 2024 press release regarding the 'Global Cancer Burden' that there were an estimated 20 million new cancer cases worldwide in 2022. Consequently, this rising caseload is directly accelerating the procurement of radiation therapy machinery as hospitals expand their oncology departments to address the essential care requirements of a growing patient demographic.

Concurrently, rapid technological evolution, specifically the incorporation of artificial intelligence, is propelling market development by transforming how treatments are delivered. Contemporary IGRT platforms now utilize adaptive algorithms capable of modifying radiation beams in real-time, which significantly refines targeting accuracy. The industry's pivot toward these adaptive systems is evidenced by strong commercial results; for instance, Accuray Incorporated reported gross orders totaling $342.1 million in its 'Fourth Quarter and Fiscal 2024 Financial Results' released in August 2024, demonstrating solid demand for precision tools. The financial magnitude of the sector is further exemplified by industry leaders like Siemens Healthineers, whose Varian segment achieved a total revenue of $4.14 billion in 2024, a figure driven by the persistent uptake of advanced radiotherapy solutions.

Market Challenge

The significant capital investment necessary for the acquisition and installation of Image-Guided Radiation Therapy (IGRT) systems presents a major impediment to the market's global expansion. These sophisticated treatment platforms require not only the procurement of costly hardware but also substantial outlays for specialized facility infrastructure, such as radiation-shielded bunkers, along with rigorous ongoing maintenance protocols. This heavy financial load establishes a steep barrier to entry that limits the capacity of healthcare institutions, especially those in resource-constrained environments, to obtain essential equipment, thereby effectively restricting the potential customer base and decelerating overall adoption rates.

This economic barrier precipitates a severe disparity in accessibility, directly hindering market penetration in developing regions where the clinical necessity is often most acute. According to the Global Coalition for Radiotherapy in 2024, approximately 58 nations worldwide lacked any radiotherapy services entirely, a deficit largely attributed to local healthcare systems' inability to finance the initial capitalization and operational expenses associated with these technologies. The lack of infrastructure in such a significant number of countries prevents manufacturers from accessing potential revenue streams in emerging markets, ultimately constraining the global industry's growth trajectory.

Market Trends

The emergence of Biologically Guided Radiation Therapy platforms marks a transformative evolution in the market, shifting focus from anatomical imaging to the utilization of tumor biology for real-time targeting. In contrast to traditional systems that depend solely on structural variations, these advanced platforms detect positron emission tomography signals released directly by the tumor, enabling the precise treatment of multiple metastatic locations in a single session. This innovation meets a critical need for managing late-stage malignancies where conventional focal therapies often prove inadequate. The rapid adoption of this technology is highlighted by regulatory advancements; as noted by RefleXion Medical in its 'RefleXion Launches Pivotal Study' press release from January 2025, updated reimbursement codes are set to expand access to SCINTIX therapy to approximately 400,000 additional patients, signaling the substantial clinical integration of biologically driven workflows.

In parallel, the integration of cloud-based treatment planning and data analytics is optimizing complex oncology workflows through centralized digital ecosystems. Healthcare institutions are increasingly moving away from isolated, on-site workstations toward interconnected software platforms that support remote plan reviews, multi-site data exchange, and improved operational productivity. This consolidation of digital resources enables clinics to effectively handle growing patient volumes without necessitating a proportional expansion of physical infrastructure. The commercial success of this trend is reflected in recent financial metrics; Elekta, in its 'Year-end report May 2024/25' released in May 2025, announced double-digit growth within its software division, a critical contributor to an adjusted EBIT margin of 16.3 percent, indicating a definitive industry shift toward software-centric models of care delivery.

Key Market Players

  • Siemens Healthineers AG
  • ViewRay, Inc.
  • Varian Medical Systems, Inc.
  • Toshiba Corporation
  • GE HealthCare Technologies, Inc.
  • Accuray Inc.
  • Becton, Dickinson, and Company
  • Vision RT Ltd.

Report Scope

In this report, the Global Image-Guided Radiation Therapy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Image-Guided Radiation Therapy Market, By Product

  • 4D RT
  • LINAC
  • MRI-guided radiotherapy
  • Portal CT Imaging

Image-Guided Radiation Therapy Market, By Procedure

  • IMRT
  • Stereotactic
  • Particle

Image-Guided Radiation Therapy Market, By Application

  • Neck
  • Prostate
  • Breast cancer

Image-Guided Radiation Therapy Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Image-Guided Radiation Therapy Market.

Available Customizations:

Global Image-Guided Radiation Therapy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Image-Guided Radiation Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging)
    • 5.2.2. By Procedure (IMRT, Stereotactic, Particle)
    • 5.2.3. By Application (Neck, Prostate, Breast cancer)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Image-Guided Radiation Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Procedure
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Image-Guided Radiation Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Procedure
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Image-Guided Radiation Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Procedure
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Image-Guided Radiation Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Procedure
        • 6.3.3.2.3. By Application

7. Europe Image-Guided Radiation Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Procedure
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Image-Guided Radiation Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Procedure
        • 7.3.1.2.3. By Application
    • 7.3.2. France Image-Guided Radiation Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Procedure
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Image-Guided Radiation Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Procedure
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Image-Guided Radiation Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Procedure
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Image-Guided Radiation Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Procedure
        • 7.3.5.2.3. By Application

8. Asia Pacific Image-Guided Radiation Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Procedure
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Image-Guided Radiation Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Procedure
        • 8.3.1.2.3. By Application
    • 8.3.2. India Image-Guided Radiation Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Procedure
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Image-Guided Radiation Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Procedure
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Image-Guided Radiation Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Procedure
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Image-Guided Radiation Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Procedure
        • 8.3.5.2.3. By Application

9. Middle East & Africa Image-Guided Radiation Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Procedure
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Image-Guided Radiation Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Procedure
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Image-Guided Radiation Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Procedure
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Image-Guided Radiation Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Procedure
        • 9.3.3.2.3. By Application

10. South America Image-Guided Radiation Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Procedure
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Image-Guided Radiation Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Procedure
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Image-Guided Radiation Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Procedure
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Image-Guided Radiation Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Procedure
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Image-Guided Radiation Therapy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Siemens Healthineers AG
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. ViewRay, Inc.
  • 15.3. Varian Medical Systems, Inc.
  • 15.4. Toshiba Corporation
  • 15.5. GE HealthCare Technologies, Inc.
  • 15.6. Accuray Inc.
  • 15.7. Becton, Dickinson, and Company
  • 15.8. Vision RT Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer